145 related articles for article (PubMed ID: 33043385)
1. Cardamonin inhibits cell proliferation by caspase-mediated cleavage of Raptor.
Zhu Y; Zhou J; Niu P; Chen H; Shi D
Naunyn Schmiedebergs Arch Pharmacol; 2021 Apr; 394(4):809-817. PubMed ID: 33043385
[TBL] [Abstract][Full Text] [Related]
2. Autophagy induced by cardamonin is associated with mTORC1 inhibition in SKOV3 cells.
Shi D; Niu P; Heng X; Chen L; Zhu Y; Zhou J
Pharmacol Rep; 2018 Oct; 70(5):908-916. PubMed ID: 30099297
[TBL] [Abstract][Full Text] [Related]
3. Raptor mediates the antiproliferation of cardamonin by mTORC1 inhibition in SKOV3 cells.
Shi D; Zhu Y; Niu P; Zhou J; Chen H
Onco Targets Ther; 2018; 11():757-767. PubMed ID: 29445291
[TBL] [Abstract][Full Text] [Related]
4. Raptor couples mTORC1 and ERK1/2 inhibition by cardamonin with oxidative stress induction in ovarian cancer cells.
Zhu Y; Wang S; Niu P; Chen H; Zhou J; Jiang L; Li D; Shi D
PeerJ; 2023; 11():e15498. PubMed ID: 37304865
[TBL] [Abstract][Full Text] [Related]
5. Raptor mediates the selective inhibitory effect of cardamonin on RRAGC-mutant B cell lymphoma.
Liu Y; Zhu Y; Chen H; Zhou J; Niu P; Shi D
BMC Complement Med Ther; 2023 Sep; 23(1):336. PubMed ID: 37749558
[TBL] [Abstract][Full Text] [Related]
6. RAPTOR promotes colorectal cancer proliferation by inducing mTORC1 and upregulating ribosome assembly factor URB1.
Wang T; Zhang WS; Wang ZX; Wu ZW; Du BB; Li LY; Chen YF; Yang XF; Hao XY; Guo TK
Cancer Med; 2020 Feb; 9(4):1529-1543. PubMed ID: 31886628
[TBL] [Abstract][Full Text] [Related]
7. mTOR inhibition of cardamonin on antiproliferation of A549 cells is involved in a FKBP12 independent fashion.
Tang Y; Fang Q; Shi D; Niu P; Chen Y; Deng J
Life Sci; 2014 Mar; 99(1-2):44-51. PubMed ID: 24508654
[TBL] [Abstract][Full Text] [Related]
8. Selective interference of mTORC1/RAPTOR protects against human disc cellular apoptosis, senescence, and extracellular matrix catabolism with Akt and autophagy induction.
Ito M; Yurube T; Kakutani K; Maeno K; Takada T; Terashima Y; Kakiuchi Y; Takeoka Y; Miyazaki S; Kuroda R; Nishida K
Osteoarthritis Cartilage; 2017 Dec; 25(12):2134-2146. PubMed ID: 28888905
[TBL] [Abstract][Full Text] [Related]
9. Anti‑proliferative effect of cardamonin on mTOR inhibitor‑resistant cancer cells.
Niu P; Li J; Chen H; Zhu Y; Zhou J; Shi D
Mol Med Rep; 2020 Mar; 21(3):1399-1407. PubMed ID: 31894316
[TBL] [Abstract][Full Text] [Related]
10. [Effect of MTRR gene on apoptosis and autophagy pathways in multiresistant epithelial ovarian cancer].
Chen J; Wang Q; Zhang W; Li L
Zhonghua Fu Chan Ke Za Zhi; 2016 Apr; 51(4):285-92. PubMed ID: 27116987
[TBL] [Abstract][Full Text] [Related]
11. Cardamonin protects against adverse cardiac remodeling through mTORC1 inhibition in mice with myocardial infarction.
You W; Wu Z; Ye F; Wu X
Pharmazie; 2018 Sep; 73(9):508-512. PubMed ID: 30223933
[TBL] [Abstract][Full Text] [Related]
12. DAP1 negatively regulates autophagy induced by cardamonin in SKOV3 cells.
Nie X; Chen H; Niu P; Zhu Y; Zhou J; Jiang L; Li D; Lin M; Chen Z; Shi D
Cell Biol Int; 2020 Nov; 44(11):2192-2201. PubMed ID: 32706448
[TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory Effects of Cardamonin in Ovarian Cancer Cells Are Mediated via mTOR Suppression.
Chen H; Shi D; Niu P; Zhu Y; Zhou J
Planta Med; 2018 Nov; 84(16):1183-1190. PubMed ID: 29772587
[TBL] [Abstract][Full Text] [Related]
14. Cardamonin Inhibits Metastasis of Lewis Lung Carcinoma Cells by Decreasing mTOR Activity.
Niu PG; Zhang YX; Shi DH; Liu Y; Chen YY; Deng J
PLoS One; 2015; 10(5):e0127778. PubMed ID: 25996501
[TBL] [Abstract][Full Text] [Related]
15. Cardamonin exerts potent activity against multiple myeloma through blockade of NF-κB pathway in vitro.
Qin Y; Sun CY; Lu FR; Shu XR; Yang D; Chen L; She XM; Gregg NM; Guo T; Hu Y
Leuk Res; 2012 Apr; 36(4):514-20. PubMed ID: 22226224
[TBL] [Abstract][Full Text] [Related]
16. Discovery of a highly active anticancer analogue of cardamonin that acts as an inducer of caspase-dependent apoptosis and modulator of the mTOR pathway.
Break MKB; Hossan MS; Khoo Y; Qazzaz ME; Al-Hayali MZK; Chow SC; Wiart C; Bradshaw TD; Collins H; Khoo TJ
Fitoterapia; 2018 Mar; 125():161-173. PubMed ID: 29355749
[TBL] [Abstract][Full Text] [Related]
17. Glycolysis inhibition via mTOR suppression is a key step in cardamonin-induced autophagy in SKOV3 cells.
Shi D; Zhao D; Niu P; Zhu Y; Zhou J; Chen H
BMC Complement Altern Med; 2018 Dec; 18(1):317. PubMed ID: 30514289
[TBL] [Abstract][Full Text] [Related]
18. The FBXW7-SHOC2-Raptor Axis Controls the Cross-Talks between the RAS-ERK and mTORC1 Signaling Pathways.
Xie CM; Tan M; Lin XT; Wu D; Jiang Y; Tan Y; Li H; Ma Y; Xiong X; Sun Y
Cell Rep; 2019 Mar; 26(11):3037-3050.e4. PubMed ID: 30865892
[TBL] [Abstract][Full Text] [Related]
19. Novel Semi-Synthetic Cu (II)-Cardamonin Complex Exerts Potent Anticancer Activity against Triple-Negative Breast and Pancreatic Cancer Cells via Inhibition of the Akt Signaling Pathway.
Hossan MS; Break MKB; Bradshaw TD; Collins HM; Wiart C; Khoo TJ; Alafnan A
Molecules; 2021 Apr; 26(8):. PubMed ID: 33918814
[TBL] [Abstract][Full Text] [Related]
20. Cardamonin Inhibits Angiogenesis by mTOR Downregulation in SKOV3 Cells.
Xue ZG; Niu PG; Shi DH; Liu Y; Deng J; Chen YY
Planta Med; 2016 Jan; 82(1-2):70-5. PubMed ID: 26393941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
